[1]
Migden, M., Rischin, D., Sasane, M., Mastey, V., Pavlick, A., Schmults, C., Chen, Z., Guminski, A., Hauschild, A., Bury, D., Hudgens, S., Chang, A.L., Rabinowits, G., Ibrahim, S., Fury, M., Lowy, I., Li, S. and Chen, C.-I. 2021. Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s5. DOI:https://doi.org/10.25251/skin.5.supp.5.